Travel & financial grants

OncoLink

This OncoLink resource page, 'Transportation Resources for Pediatric Cancer Patients', compiles a list of external organizations that offer travel assistance. It outlines various programs that help with costs such as flights, gas, lodging, and meals for pediatric cancer patients and their families. Eligibility and application details are specific to each listed organization, not OncoLink itself.

Novartis Oncology

This is the Novartis Oncology Universal Co-pay Program, offering financial assistance for out-of-pocket medication costs for eligible Novartis Oncology products like Tykerb. It is available to US residents (excluding Massachusetts, with additional criteria for California) who have commercial insurance and are not enrolled in government healthcare programs. The program covers up to $30,000 per calendar year for medication co-pays, after the patient pays an initial $10 co-pay per 30-day supply.

UCB Canada Inc.

The UCB Cares Patient Support Program provides support and helpful resources to patients prescribed CIMZIA® or BIMZELX® and their physicians throughout their treatment journey. The program aims to assist with various aspects of managing these conditions.

United Therapeutics

The United Therapeutics Patient Support Programs, primarily through United Therapeutics Cares, offer personalized education, insurance navigation, and general financial support options for out-of-pocket treatment costs. The provided content does not explicitly mention coverage for travel expenses such as flights, hotel, or gas.

PAN Foundation

The PAN Foundation offers transportation grants to help patients cover the costs of transportation purchases. Applicants must verify their income or insurance premium and find their specific disease fund to check eligibility for assistance.

The Assistance Fund

The Uveitis Copay Assistance Program, administered by The Assistance Fund, provides financial assistance for out-of-pocket costs such as copays, deductibles, and coinsurance for FDA-approved treatments for Uveitis. To qualify, patients must be U.S. citizens or permanent residents, diagnosed with Uveitis, have prescription coverage, and meet financial eligibility criteria. The program is currently accepting patients to join its waitlist.

Helsinn Therapeutics (U.S.), Inc.

The VALCHLOR copay program by Helsinn Therapeutics provides financial assistance for VALCHLOR® (mechlorethamine) gel 0.016% medication. It is available to US and Puerto Rico residents aged 18 or older who have commercial health insurance, ensuring access to treatment through direct shipping.

Helsinn Therapeutics, Inc.

The Valchlor Support patient program provides financial assistance for the cost of the VALCHLOR prescription, not for travel expenses. Eligible patients with commercial health insurance in the US and Puerto Rico, aged 18 or older, can receive copay assistance, reducing their out-of-pocket cost to $0 per prescription fill.

Amgen Canada

The VICTORY Patient Support Program, sponsored by Amgen Canada, assists patients prescribed Vectibix® or Kyprolis®. It offers reimbursement for travel expenses like transportation and lodging, alongside support for out-of-pocket skincare products and specific HCP-recommended medical items. Eligibility for program services is determined based on prescription and drug plan details.

Bausch

The WD Rx Access program, sponsored by Bausch, offers patient assistance for Cuprimine and Syprine medications. It is open for eligible patients, including an enhanced program for Medicaid-only patients beginning October 1st. Patients need to re-enroll annually for assistance.

Wilson Disease Association

The Wilson Disease Association Patient Assistance Program page primarily outlines various initiatives focused on providing or facilitating access to prescription medications for Wilson disease patients. It details specific drug assistance programs from pharmaceutical companies for U.S. patients and an international medication assistance program. This page does not offer any grants specifically for travel assistance.

Karyopharm Therapeutics Inc.

The XPOVIO Copay Program, offered by Karyopharm Therapeutics Inc. through its KaryForward patient support program, provides financial assistance to eligible patients for their XPOVIO prescriptions. Qualified individuals may pay as little as $5 per prescription or receive the medication at no cost. While primarily covering prescription costs, the KaryForward program also offers referrals for third-party transportation assistance and other patient resources.

Blueprint Medicines Corporation

This page details financial assistance programs offered by YourBlueprint, primarily focusing on co-pay assistance for prescriptions (up to $25,000 annually) and a patient assistance program providing free medication. It does not mention or describe any specific patient travel assistance grant or coverage for travel-related expenses.

Accessia Health

This Accessia Health program provides up to $4500 annually in financial assistance for patients with Gastrointestinal Stromal Tumors (GIST) who have public insurance. Support may cover medication copayments, premiums, ancillary services, and travel expenses. Eligibility is needs-based, requires US or Puerto Rico residency, and applicants must provide income, diagnosis, and insurance documentation.

Accessia Health

The Accessia Health GIST program provides financial assistance for patients with Gastrointestinal Stromal Tumors, covering medication copayments, premiums, ancillary services, infusion, nursing, and travel. Eligible applicants must be residents of the US or Puerto Rico, have public insurance (Medicare/Medicaid), and demonstrate financial need, requiring income documentation.

Accessia Health

The Accessia Health program offers financial assistance for patients with Gastrointestinal Stromal Tumors (GIST) who have public insurance (Medicare/Medicaid) and demonstrate financial need. This grant covers medication copayments, premiums, ancillary services, infusion, nursing services, and travel, with an annual maximum benefit of $4500. Applicants must reside in the US or Puerto Rico and provide income documentation.

Accessia Health

The Accessia Health Myelodysplastic Syndromes grant offers financial support for patients with myelodysplastic syndromes who reside in the US or Puerto Rico. Benefits may include copayment, premium, ancillary services, infusion and nursing services, or travel. The program is needs-based, requires supporting income documentation, and is currently accepting applications for a waitlist.

Accessia Health

This Accessia Health program provides up to $3800 annually for US and Puerto Rico residents with Primary Immune Deficiency and public insurance (Medicare/Medicaid). It offers financial assistance for copayments, premiums, ancillary services, infusion/nursing, and travel. Applicants must demonstrate financial need with income documentation; however, the program is currently on a waitlist and not funded, meaning applications are not actively being processed for awards.

Accessia Health

The Accessia Health GIST program provides needs-based financial assistance for patients with Gastrointestinal Stromal Tumors, covering copayment, premium, ancillary services, infusion, nursing, and travel. Eligible applicants must reside in the US or Puerto Rico, have Medicare or Medicaid insurance, and provide income documentation. The program offers a $4500 annual maximum benefit, and applications are currently on a waitlist.

Accessia Health

This Accessia Health program offers an annual maximum benefit of $5500 to assist with copayments, premiums, ancillary services, infusion and nursing services, and travel. It is available to US and Puerto Rico residents with Medicare/Medicaid who require Aldurazyme and meet financial and medical eligibility, including providing income documentation.

The Assistance Fund

The Acromegaly Financial Assistance Program, sponsored by The Assistance Fund, provides financial grants to help patients with out-of-pocket medical costs, including prescription drug copays, health insurance premiums, therapy administration, and travel expenses for treatment. To qualify, patients must be U.S. citizens or permanent residents diagnosed with Acromegaly, prescribed an FDA-approved treatment with coverage, and meet financial eligibility based on household income and size. The program is currently operating on a waitlist basis.

The Assistance Fund

The Assistance Fund: Infantile Spasms: Waitlist program offers financial assistance for copays, coinsurance, deductibles, health insurance premiums, and other medical expenses related to FDA-approved and potentially off-label treatments for infantile spasms. It supports eligible patients under the age of 2 who are US or Puerto Rico residents, are commercially insured or have Medicare/Medicaid, and whose applicants must be 18 years or older. Eligibility is needs-based.

The Assistance Fund

The Assistance Fund: Small Cell Lung Cancer (SCLC) program offers financial support for eligible SCLC patients residing in the US and Puerto Rico, who are commercially insured or covered by Medicare/Medicaid and demonstrate financial need. It covers copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses for FDA-approved and potentially off-label treatments. The program is currently operating on a waitlist.

Patient Access Network (PAN) Foundation

The PAN: Non-Hodgkin's Lymphoma (Medicare): Waitlist program offers financial assistance for medication costs to eligible US and Puerto Rico residents with Medicare coverage for Non-Hodgkin's Lymphoma. It provides an annual maximum benefit of $3600 and is needs-based, requiring patients to meet specific income criteria to qualify for funding for drugs like Rituxan, Revlimid, and Imbruvica.

QuickRx

This QuickRx grant provides copay assistance for Pomalyst (pomalidomide) medication to patients with multiple myeloma. It helps commercially insured, Medicare, Medicaid, and uninsured patients reduce out-of-pocket costs to $0 by coordinating manufacturer copay cards, patient assistance programs, and foundation grants. The assistance also includes insurance benefit verification, prior authorization support, and nationwide home delivery.